Morepen Labs names Kushal Suri as President - International Growth
Advertisement
Baddi: Morepen Labs has announced the redesignation of Senior Management Personnel, Kushal Suri, as President - International Growth. He previously held the position of Director – API Sales & Marketing.
The company disclosed the leadership change in a regulatory filing with the BSE, stating, "We wish to inform you that the designation of Mr. Kushal Suri, Senior Management Personnel, has been changed from "Director – API Sales & Marketing" to "President – International Growth," with effect from April 28, 2025.".
Kushal Suri holds an M.B.A. degree from Regent’s University, London (UK), with a major in Marketing and a minor in Consultancy, along with various other accolades from Harvard University, Cambridge (USA). In the past, he has worked with international organizations such as Houlihan Lokey, Singapore. Kushal Suri is the nephew of Sushil Suri, Chairman & Managing Director, and Sanjay Suri, Whole-Time Director of the Company.
Read also: Morepen Labs receives anti-allergy API Loratadine approval for export to China
Morepen Laboratories Ltd. is an Indian pharmaceutical company with a global footprint across 82 countries. All APIs are manufactured in-house at USFDA-approved facilities.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.